Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection
- PMID: 10704054
- PMCID: PMC1781793
- DOI: 10.1080/09629359990496
Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection
Abstract
Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa infection. In this study the relationship between P. aeruginosa status and inflammatory markers has been investigated. Seventeen CF children in acute lung exacerbation were examined. CF patients without P. aeruginosa infection were characterized by elevated activity of sputum elastase, reduced response of peripheral blood lymphocytes to PHA and significant resistance to the antiproliferative action of glucocorticoids. These parameters were normalized after antibiotic treatment. The patients with prolonged P. aeruginosa infection demonstrated extremely high levels of elastase activity and elevated amounts of sputum IL-8 and TNF-alpha. Although antibiotic treatment resulted in clinical improvement, it failed to suppress excessive immune response in the lung. The data indicate that CF patients with prolonged P. aeruginosa need the modified treatment, which should include immunomodulating drugs and protease inhibitors as well as antibacterial therapy.
Similar articles
-
[Immunologic monitoring of patients with cystic fibrosis: value of different laboratory findings].Vestn Ross Akad Med Nauk. 2000;(5):40-6. Vestn Ross Akad Med Nauk. 2000. PMID: 10881662 Russian.
-
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa.Eur Respir J. 2003 Sep;22(3):503-6. doi: 10.1183/09031936.03.00004503. Eur Respir J. 2003. PMID: 14516142
-
Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.Clin Exp Immunol. 2021 Sep;205(3):391-405. doi: 10.1111/cei.13624. Epub 2021 Jun 16. Clin Exp Immunol. 2021. PMID: 34031873 Free PMC article.
-
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.Eur Respir J. 2000 Oct;16(4):749-67. doi: 10.1034/j.1399-3003.2000.16d30.x. Eur Respir J. 2000. PMID: 11106223 Review.
-
Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches.Expert Rev Respir Med. 2016 Jun;10(6):685-97. doi: 10.1080/17476348.2016.1177460. Epub 2016 May 13. Expert Rev Respir Med. 2016. PMID: 27175979 Review.
Cited by
-
Neutrophil cell death, activation and bacterial infection in cystic fibrosis.Thorax. 2005 Aug;60(8):659-64. doi: 10.1136/thx.2004.038240. Thorax. 2005. PMID: 16061707 Free PMC article.
-
Sputum biomarkers of inflammation in cystic fibrosis lung disease.Proc Am Thorac Soc. 2007 Aug 1;4(4):406-17. doi: 10.1513/pats.200703-044BR. Proc Am Thorac Soc. 2007. PMID: 17652508 Free PMC article. Review.
-
Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients.Mediators Inflamm. 2001 Apr;10(2):61-7. doi: 10.1080/09629350120054527. Mediators Inflamm. 2001. PMID: 11405551 Free PMC article.
-
Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.Microbiology (Reading). 2014 Mar;160(Pt 3):547-555. doi: 10.1099/mic.0.075325-0. Epub 2014 Jan 2. Microbiology (Reading). 2014. PMID: 24385476 Free PMC article.
-
Monitoring inflammation in CF. Cytokines.Clin Rev Allergy Immunol. 2002 Aug;23(1):41-57. doi: 10.1385/CRIAI:23:1:041. Clin Rev Allergy Immunol. 2002. PMID: 12162105 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical